Related references
Note: Only part of the references are listed.Planning experiments: Updated guidance on experimental design and analysis and their reporting III
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Neuron-specific translational control shift ensures proteostatic resilience during ER stress
Kimberly Wolzak et al.
EMBO JOURNAL (2022)
The Role and Therapeutic Potential of the Integrated Stress Response in Amyotrophic Lateral Sclerosis
Elias Marlin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives
Tiziana Bonifacino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial
Eleonora Dalla Bella et al.
BRAIN (2021)
Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS
Mariana Bravo-Hernandez et al.
NATURE MEDICINE (2020)
Fine tuning of the unfolded protein response by ISRIB improves neuronal survival in a model of amyotrophic lateral sclerosis
Ricardo Bugallo et al.
CELL DEATH & DISEASE (2020)
N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity
Rodrigo Vinueza-Gavilanes et al.
NEUROBIOLOGY OF DISEASE (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS
Yulia Dzhashiashvili et al.
NEUROBIOLOGY OF DISEASE (2019)
Activation of the ISR mediates the behavioral and neurophysiological abnormalities in Down syndrome
Ping Jun Zhu et al.
SCIENCE (2019)
eIF2B activator prevents neurological defects caused by a chronic integrated stress response
Yao Liang Wong et al.
ELIFE (2019)
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
Steve P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Stress Granule Assembly Disrupts Nucleocytoplasmic Transport
Ke Zhang et al.
CELL (2018)
The Unfolded Protein Response and Cell Fate Control
Claudio Hetz et al.
MOLECULAR CELL (2018)
CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity
Nicholas J. Kramer et al.
NATURE GENETICS (2018)
The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes
Yao Liang Wong et al.
ELIFE (2018)
E46K alpha-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation
Ignacio Inigo-Marco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Role of Endoplasmic Reticulum Stress in Learning and Memory Impairment and Alzheimer's Disease-Like Neuropathology in the PS19 and APPSwe Mouse Models of Tauopathy and Amyloidosis
Denise Isabelle Briggs et al.
ENEURO (2017)
The integrated stress response
Karolina Pakos-Zebrucka et al.
EMBO REPORTS (2016)
Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS
Shuying Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit
Indrajit Das et al.
SCIENCE (2015)
Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity
M. Halliday et al.
CELL DEATH & DISEASE (2015)
The small molecule ISRIB reverses the effects of elF2α phosphorylation on translation and stress granule assembly
Carmela Sidrauski et al.
ELIFE (2015)
Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models
Hyung-Jun Kim et al.
NATURE GENETICS (2014)
Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis
Lijun Wang et al.
NEUROBIOLOGY OF DISEASE (2014)
GUANABENZ DELAYS THE ONSET OF DISEASE SYMPTOMS, EXTENDS LIFESPAN, IMPROVES MOTOR PERFORMANCE AND ATTENUATES MOTOR NEURON LOSS IN THE SOD1 G93A MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS
H. -Q. Jiang et al.
NEUROSCIENCE (2014)
Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin
Jing Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
One Universal Common Endpoint in Mouse Models of Amyotrophic Lateral Sclerosis
Jesse A. Solomon et al.
PLOS ONE (2011)
A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice
Smita Saxena et al.
NATURE NEUROSCIENCE (2009)
Time course of preferential motor unit loss in the SODIG93A mouse model of amyotrophic lateral sclerosis
J. Hegedus et al.
NEUROBIOLOGY OF DISEASE (2007)
The heterogeneity of amyotrophic lateral sclerosis:: A possible explanation of treatment failure
Ettore Beghi et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Optimal methods to characterize the G93A mouse model of ALS
FJ Miana-Mena et al.
AMYOTROPHIC LATERAL SCLEROSIS (2005)
Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α
I Novoa et al.
JOURNAL OF CELL BIOLOGY (2001)
Perk is essential for translational regulation and cell survival during the unfolded protein response
HP Harding et al.
MOLECULAR CELL (2000)
Share Paper
